small molecule

INDOCIN

INDOMETHACIN

Loss of exclusivityloss of exclusivity
CompanyZYLA LIFE SCIENCES US INC

Drug detail

Brand nameINDOCIN
Active ingredientINDOMETHACIN
Strength25MG/5ML
Dosage formSUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalOctober 1985
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

INDOCIN patent cliff — loss of exclusivity — | CliffBio